LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | GSK1059615 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 6304 | 5905 | 1.0686 | 1.0648 |
MCF7 | GSK1059615 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 5101 | 5445 | 0.9340 | 0.9285 |
MCF7 | GSK1059615 | 0.12 | uM | LJP5 | 72 | hr | 1389 | 5372 | 5905 | 0.9099 | 0.9116 |
MCF7 | GSK1059615 | 0.12 | uM | LJP6 | 72 | hr | 1389 | 4636 | 5445 | 0.8505 | 0.8406 |
MCF7 | GSK1059615 | 0.37 | uM | LJP5 | 72 | hr | 1389 | 4309 | 5905 | 0.7283 | 0.7157 |
MCF7 | GSK1059615 | 0.37 | uM | LJP6 | 72 | hr | 1389 | 3382 | 5445 | 0.6215 | 0.5704 |
MCF7 | GSK1059615 | 1.11 | uM | LJP5 | 72 | hr | 1389 | 2462 | 5905 | 0.4159 | 0.3110 |
MCF7 | GSK1059615 | 1.11 | uM | LJP6 | 72 | hr | 1389 | 2286 | 5445 | 0.4200 | 0.2869 |
MCF7 | GSK1059615 | 3.33 | uM | LJP5 | 72 | hr | 1389 | 1373 | 5905 | 0.2326 | -0.0055 |
MCF7 | GSK1059615 | 3.33 | uM | LJP6 | 72 | hr | 1389 | 1711 | 5445 | 0.3142 | 0.1104 |
MCF7 | GSK1059615 | 10 | uM | LJP5 | 72 | hr | 1389 | 1167 | 5905 | 0.1974 | -0.0811 |
MCF7 | GSK1059615 | 10 | uM | LJP6 | 72 | hr | 1389 | 1060 | 5445 | 0.1945 | -0.1299 |
MCF7 | Brivanib | 0.04 | uM | LJP5 | 72 | hr | 1389 | 5347 | 5905 | 0.9055 | 0.9071 |
MCF7 | Brivanib | 0.12 | uM | LJP5 | 72 | hr | 1389 | 5251 | 5905 | 0.8878 | 0.8868 |
MCF7 | Brivanib | 0.37 | uM | LJP5 | 72 | hr | 1389 | 5637 | 5905 | 0.9545 | 0.9557 |
MCF7 | Brivanib | 1.11 | uM | LJP5 | 72 | hr | 1389 | 5582 | 5905 | 0.9454 | 0.9469 |
MCF7 | Brivanib | 3.33 | uM | LJP5 | 72 | hr | 1389 | 5732 | 5905 | 0.9707 | 0.9718 |
MCF7 | Brivanib | 10 | uM | LJP5 | 72 | hr | 1389 | 5061 | 5905 | 0.8565 | 0.8564 |
MCF7 | CHIR-99021 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 4320 | 5445 | 0.7878 | 0.7573 |
MCF7 | CHIR-99021 | 0.12 | uM | LJP6 | 72 | hr | 1389 | 4171 | 5445 | 0.7600 | 0.7214 |
MCF7 | CHIR-99021 | 0.37 | uM | LJP6 | 72 | hr | 1389 | 4034 | 5445 | 0.7352 | 0.6959 |
MCF7 | CHIR-99021 | 1.11 | uM | LJP6 | 72 | hr | 1389 | 3139 | 5445 | 0.5724 | 0.4957 |
MCF7 | CHIR-99021 | 3.33 | uM | LJP6 | 72 | hr | 1389 | 3384 | 5445 | 0.6164 | 0.5502 |
MCF7 | CHIR-99021 | 10 | uM | LJP6 | 72 | hr | 1389 | 2034 | 5445 | 0.3718 | 0.2058 |
MCF7 | Linifanib | 0.04 | uM | LJP6 | 72 | hr | 1389 | 5459 | 5445 | 1.0031 | 1.0034 |